MarketCapTrends
DARE

Dare Bioscience Inc. (DARE)

NASDAQ · Healthcare

Dare Bioscience Inc. annual/quarterly shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Dare Bioscience Inc. shareholder equity for the quarter ending December 31, 2025 were 2.8M, a 147.28% decrease year-over-year.
  • Dare Bioscience Inc. shareholder equity for 2025 were 2.8M, a 147.28% decrease from 2024.
  • Dare Bioscience Inc. shareholder equity for 2024 were -6.0M, a 19.11% increase from 2023.
  • Dare Bioscience Inc. shareholder equity for 2023 were -5.0M, a 145.42% decrease from 2022.
  • Dare Bioscience Inc. shareholder equity for 2022 were 11.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Dare Bioscience Inc. Annual Shareholder Equity (Millions of US $)
2025$3
2024$-6
2023$-5
2022$11
2021$39
2016$-1
2014$45
2013$-94
Dare Bioscience Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$3
2024-12-31$-6
2023-12-31$-5
2022-12-31$11
2021-12-31$39
2016-12-31$-1
2014-12-31$45
2013-12-31$-94

Dare Bioscience Inc. Shareholder Equity — FAQ

Dare Bioscience Inc. (DARE) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DARE's shareholder equity history?

The chart and table above show Dare Bioscience Inc.'s shareholder equity by year and by quarter, including the growth rate.